Palleos successfully completed recruitment across three countries for a double-blind, placebo-controlled phase 2b trial in chronic discogenic lower back pain despite the toughest months of COVID-19. Leveraging expert biostatistic services, medical writing, and clinical trials services in Germany and Europe, the team expanded beyond traditional sites by engaging over 500 radiologists and specialized MRI facilities, launching social media advertising, and hosting live broadcasts with a coordinating PI. The result: 110 patients enrolled, a low dropout rate, and a sponsor who praised the team’s resilience and efficiency. Turn your biggest challenge into a milestone.
Need clinical research solutions for your next trial? Contact us at info@palleos.com.
